L - Trademark Details
Status: 604 - Abandoned - After Inter-Partes Decision
Serial Number
87425805
Word Mark
L
Status
604 - Abandoned - After Inter-Partes Decision
Status Date
2018-01-27
Filing Date
2017-04-26
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261503, 261528, 261904, 270104 - Incomplete polygons and polygons made of broken or dotted lines. Miscellaneous designs with overall polygon shape. Cubes. Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps.
Published for Opposition Date
2017-09-19
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
KEELEY, ALISON REBECCA
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward.
Goods and Services
Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
Pseudo Mark
LLL
Pseudo Mark
L L L
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2018-01-27
Primary Code
005
Correspondences
Name
TIMOTHY T WANG
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2017-04-29 | NEW APPLICATION ENTERED IN TRAM |
| 2017-05-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-05-04 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2017-07-24 | ASSIGNED TO EXAMINER |
| 2017-07-27 | EXAMINERS AMENDMENT -WRITTEN |
| 2017-07-27 | EXAMINERS AMENDMENT E-MAILED |
| 2017-07-27 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2017-07-27 | EXAMINER'S AMENDMENT ENTERED |
| 2017-07-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-08-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2017-09-19 | PUBLISHED FOR OPPOSITION |
| 2017-09-19 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2017-10-19 | OPPOSITION PAPERS RECEIVED AT TTAB |
| 2017-10-19 | OPPOSITION INSTITUTED NO. 999999 |
| 2018-01-27 | OPPOSITION SUSTAINED NO. 999999 |
| 2018-01-27 | OPPOSITION TERMINATED NO. 999999 |
| 2018-01-27 | ABANDONMENT - AFTER INTER PARTES DECISION |
| 2018-01-29 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION |
